YOUNG KEVIN 4
4 · GILEAD SCIENCES INC · Filed Feb 2, 2018
Insider Transaction Report
Form 4
YOUNG KEVIN
EVP, Commercial Operations
Transactions
- Tax Payment
Common Stock
2018-01-31$83.80/sh−2,259$189,304→ 14,927 total - Exercise/Conversion
Common Stock
2018-02-01+620→ 15,547 total - Exercise/Conversion
Restricted Stock Unit
2018-02-01−620→ 4,092 total→ Common Stock (620 underlying) - Award
Common Stock
2018-01-31+7,110→ 17,186 total - Tax Payment
Common Stock
2018-02-01$83.49/sh−218$18,201→ 15,329 total
Footnotes (3)
- [F1]Issuance of common stock upon vesting of certain performance share awards on January 31, 2018.
- [F2]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F3]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.